NEVRO CORP (NVRO)
US64157F1030 - Common Stock
Get insights into the top gainers and losers of Monday's after-hours session.
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Nevro Reports Third-Quarter 2024 Financial Results
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Noteworthy Tuesday Option Activity: FSLR, TMCI, NVRO
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Nevro Becomes Oversold (NVRO)
Nevro to Present at Wells Fargo 2024 Healthcare Conference
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Oversold Conditions For Nevro (NVRO)
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!
NVRO Stock Earnings: Nevro Beats EPS, Misses Revenue for Q2 2024
NVRO stock results show that Nevro beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Nevro Reports Second-Quarter 2024 Financial Results
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Noteworthy Wednesday Option Activity: NVRO, AZZ, PNC
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Nevro to Present at Truist Securities MedTech Conference
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Noteworthy Friday Option Activity: SIX, AMZN, NVRO
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Notable Wednesday Option Activity: COIN, NVRO, PRGO
Nevro to Present at BofA Securities 2024 Healthcare Conference
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024
NVRO stock results show that Nevro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nevro (NYSE:NVRO) just reported results for the first quarter of 2024.Nevro rep...
Oversold Conditions For Nevro
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off